Physician

Ziad F Issa, M.D.

According to 2025 Medicare claims, Ziad Issa, M.D. (NPI: 1740362094) practices cardiac electrophysiology in the Springfield, IL market, with the plurality of this provider's patient population coming from Sangamon, IL. This provider's primary affiliated billing organization is PRAIRIE CARDIOVASCULAR CONSULTANTS LTD (NPI: 1982714218; TIN: 371071858) and primary practice location at 62769-5324. Issa is affiliated with the IRCCO (ACO ID: A2619), HSHS ACO, L.L.C. (ACO ID: A2783), and SSM IL ACO, LLC (ACO ID: A4832), participating under the MSSP model.

Issa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,238 traditional Medicare patients, billed 6,631 HCPCS/CPT codes, and received $537,148 in Medicare payments. The top billing code was 93294 (Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days). Part D data shows 2,220 prescription claims across 431 beneficiaries totaling $1,011,701 in drug costs, led by Eliquis (Apixaban). DME data shows 15 claims. Open Payments data shows 70 records totaling $85,780. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $533,714 to $1,011,701. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$319K$639K2015 Medicare payment: $483,580 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $455,062 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $453,849 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $521,520 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $465,995 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $515,809 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $502,944 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $579,662 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $638,597 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $537,148 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2857,140$483,580
20161,2806,681$455,062
20171,3306,623$453,849
20181,2966,915$521,520
20191,3516,490$465,995
20201,1846,230$515,809
20211,0815,728$502,944
20221,2256,102$579,662
20231,6127,528$638,597
20241,2386,631$537,148

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$507K$1.0M2015 Drug cost: $533,714 (USD; Tot_Drug_Cst)2016 Drug cost: $671,948 (USD; Tot_Drug_Cst)2017 Drug cost: $629,871 (USD; Tot_Drug_Cst)2018 Drug cost: $696,595 (USD; Tot_Drug_Cst)2019 Drug cost: $827,959 (USD; Tot_Drug_Cst)2020 Drug cost: $909,089 (USD; Tot_Drug_Cst)2021 Drug cost: $821,399 (USD; Tot_Drug_Cst)2022 Drug cost: $971,157 (USD; Tot_Drug_Cst)2023 Drug cost: $1,013,151 (USD; Tot_Drug_Cst)2024 Drug cost: $1,011,701 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153482,332$533,714
20163512,337$671,948
20173841,936$629,871
20184082,041$696,595
20194252,302$827,959
20204292,308$909,089
20214132,083$821,399
20224292,344$971,157
20234172,214$1,013,151
20244312,220$1,011,701

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$39K2015 Medicare payment: $31,735 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,390 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,770 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $33,744 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,146 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,450 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $26,040 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,581 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $39,061 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20154760$31,735
20163636$2,390
20172626$1,770
2018N/R16$33,744
2019N/RN/RN/R
20202626$2,146
20214242$3,450
20221425$26,040
20231717$1,581
2024N/R15$39,061

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93294Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days348819$19
93296Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days5401,298$13
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report224244$8
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only408470$6
93005Routine electrocardiogram (ecg) using at least 12 leads with tracing405466$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban70137,045$719,171
XareltoRivaroxaban1487,440$141,858
DofetilideDofetilide26117,318$109,854
Flecainide AcetateFlecainide Acetate21314,884$8,350
Propafenone Hcl ErPropafenone Hcl221,260$4,466

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
K0606Automatic external defibrillator, with integrated electrocardiogram analysis, garment typeYN/R15$39,061

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.42$26,021Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.28$59,759Boston Scientific Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ziad F. Issa, M.D.?

Tedicare shows public-source Medicare data for Ziad F. Issa, M.D. (NPI 1740362094), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ziad F. Issa, M.D. have ACO affiliation data?

Ziad F. Issa, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), HSHS ACO, L.L.C. (MSSP, ACO ID A2783), and SSM IL ACO, LLC (MSSP, ACO ID A4832).

What billing organization is linked to Ziad F. Issa, M.D.?

Ziad F. Issa, M.D. is linked to PRAIRIE CARDIOVASCULAR CONSULTANTS LTD (billing NPI 1982714218) in the available physician profile data.

Does Ziad F. Issa, M.D. have Open Payments data?

Ziad F. Issa, M.D. has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.